메뉴 건너뛰기




Volumn 11, Issue 10, 2016, Pages

Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry

(2,927)  Haas, Sylvia a   Cate, Hugo Ten b   Accetta, Gabriele c   Angchaisuksiri, Pantep d   Bassand, Jean Pierre c,e   John Camm, A f   Corbalan, Ramon g   Darius, Harald h   Fitzmaurice, David A i   Goldhaber, Samuel Z j   Goto, Shinya k   Jacobson, Barry l   Kayani, Gloria c   Mantovani, Lorenzo G m   Misselwitz, Frank n   Pieper, Karen o   Schellong, Sebastian M p   Stepinska, Janina q   Turpie, Alexander G G r   Eickels, Martin Van n   more..


Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; ANTICOAGULANT AGENT; ANTIPLATYHELMINTIC AGENT; VITAMIN K GROUP;

EID: 84994045395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164076     Document Type: Article
Times cited : (131)

References (24)
  • 1
    • 0033527355 scopus 로고    scopus 로고
    • Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
    • PMID: 10507957
    • Hart RG, Benavente O, McBride R, Pearce LA. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis. Ann Intern Med. 1999; 131(7):492-501. PMID: 10507957.
    • (1999) Ann Intern Med , vol.131 , Issue.7 , pp. 492-501
    • Hart, R.G.1    Benavente, O.2    McBride, R.3    Pearce, L.A.4
  • 2
    • 83555164615 scopus 로고    scopus 로고
    • International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global anticoagulant registry in the field (garfield)
    • e1 PMID: 22172431
    • Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. International longitudinal registry of patients with atrial fibrillation at risk of stroke: Global Anticoagulant Registry in the FIELD (GARFIELD). Am Heart J. 2012; 163(1):13-9.e1. doi: 10.1016/j.ahj.2011.09.011 PMID: 22172431.
    • (2012) Am Heart J , vol.163 , Issue.1 , pp. 13-19
    • Kakkar, A.K.1    Mueller, I.2    Bassand, J.P.3    Fitzmaurice, D.A.4    Goldhaber, S.Z.5    Goto, S.6
  • 3
    • 84877978738 scopus 로고    scopus 로고
    • Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: Perspectives from the international, observational, prospective garfield registry
    • Epub 2013/05/25. PMID: 23704912; PubMed Central PMCID: PMC3660389
    • Kakkar AK, Mueller I, Bassand JP, Fitzmaurice DA, Goldhaber SZ, Goto S, et al. Risk profiles and antithrombotic treatment of patients newly diagnosed with atrial fibrillation at risk of stroke: perspectives from the international, observational, prospective GARFIELD registry. PLoS One. 2013; 8(5): e63479. Epub 2013/05/25. doi: 10.1371/journal.pone.0063479 PMID: 23704912; PubMed Central PMCID: PMC3660389.
    • (2013) PLoS One , vol.8 , Issue.5 , pp. e63479
    • Kakkar, A.K.1    Mueller, I.2    Bassand, J.P.3    Fitzmaurice, D.A.4    Goldhaber, S.Z.5    Goto, S.6
  • 4
    • 84875508668 scopus 로고    scopus 로고
    • 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the european heart rhythm association
    • PMID: 22923145
    • Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation-developed with the special contribution of the European Heart Rhythm Association. Europace. 2012; 14(10):1385-413. doi: 10.1093/europace/eus305 PMID: 22923145.
    • (2012) Europace , vol.14 , Issue.10 , pp. 1385-1413
    • Camm, A.J.1    Lip, G.Y.2    De Caterina, R.3    Savelieva, I.4    Atar, D.5    Hohnloser, S.H.6
  • 5
    • 84916931073 scopus 로고    scopus 로고
    • 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: Executive summary: A report of the american college of cardiology/american heart association task force on practice guidelines and the heart rhythm society
    • PMID: 24682348
    • January CT, Wann LS, Alpert JS, Calkins H, Cigarroa JE, Cleveland JC Jr., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society. Circulation. 2014; 130(23):2071-104. doi: 10.1161/CIR. 0000000000000040 PMID: 24682348.
    • (2014) Circulation , vol.130 , Issue.23 , pp. 2071-2104
    • January, C.T.1    Wann, L.S.2    Alpert, J.S.3    Calkins, H.4    Cigarroa, J.E.5    Cleveland, J.C.6
  • 6
    • 84982915243 scopus 로고    scopus 로고
    • Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists
    • PMID: 27071942
    • Fitzmaurice DA, Accetta G, Haas S, Kayani G, Lucas Luciardi H, Misselwitz F, et al. Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists. Br J Haematol. 2016. doi: 10.1111/bjh.14084 PMID: 27071942.
    • (2016) Br J Haematol
    • Fitzmaurice, D.A.1    Accetta, G.2    Haas, S.3    Kayani, G.4    Lucas Luciardi, H.5    Misselwitz, F.6
  • 7
    • 0027531953 scopus 로고
    • A method to determine the optimal intensity of oral anticoagulant therapy
    • PMID: 8470047
    • Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993; 69(3):236-9. PMID: 8470047.
    • (1993) Thromb Haemost , vol.69 , Issue.3 , pp. 236-239
    • Rosendaal, F.R.1    Cannegieter, S.C.2    Van Der Meer, F.J.3    Briet, E.4
  • 8
    • 84993996415 scopus 로고    scopus 로고
    • NICE Atrial fibrillation: management2014 16 Mar 2016
    • NICE. Atrial fibrillation: management2014 16 Mar 2016. Available from: http://www.nice.org.uk/ guidance/cg180/resources/guidance-atrial-fibrillation-the-management-of-atrial-fibrillation-pdf.
  • 9
    • 84899714733 scopus 로고    scopus 로고
    • Differences among western european countries in anticoagulation management of atrial fibrillation. Data from the prefer in af registry
    • PMID: 24651882
    • Le Heuzey JY, Ammentorp B, Darius H, De Caterina R, Schilling RJ, Schmitt J, et al. Differences among western European countries in anticoagulation management of atrial fibrillation. Data from the PREFER IN AF registry. Thromb Haemost. 2014; 111(5):833-41. doi: 10.1160/TH13-12-1007 PMID: 24651882.
    • (2014) Thromb Haemost , vol.111 , Issue.5 , pp. 833-841
    • Le Heuzey, J.Y.1    Ammentorp, B.2    Darius, H.3    De Caterina, R.4    Schilling, R.J.5    Schmitt, J.6
  • 10
    • 84904962887 scopus 로고    scopus 로고
    • Guidelines for pharmacotherapy of atrial fibrillation (JCS 2013)
    • PMID: 24965079
    • JCS Joint Working Group. Guidelines for Pharmacotherapy of Atrial Fibrillation (JCS 2013). Circ J. 2014; 78(8):1997-2021. PMID: 24965079.
    • (2014) Circ J , vol.78 , Issue.8 , pp. 1997-2021
  • 11
    • 84882453013 scopus 로고    scopus 로고
    • The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation
    • Ogawa S, Aonuma K, Tse H-F, Huang D, Huang J-L, Kalman J, et al. The APHRS's 2013 statement on antithrombotic therapy of patients with nonvalvular atrial fibrillation. Journal of Arrhythmia. 2013; 29 (3):190-200.
    • Journal of Arrhythmia , vol.2013 , Issue.29 , pp. 190-200
    • Ogawa, S.1    Aonuma, K.2    Tse, H.-F.3    Huang, D.4    Huang, J.-L.5    Kalman, J.6
  • 12
    • 84993996410 scopus 로고    scopus 로고
    • Federatie van Nederlandse Trombosediensten. De kunst van het doseren: Richtlijn, leidraad en informatie voor het doseren van vitamine K-antagonisten2015 16 May 2016 Available from
    • Federatie van Nederlandse Trombosediensten. De kunst van het doseren: Richtlijn, leidraad en informatie voor het doseren van vitamine K-antagonisten2015 16 May 2016;. Available from: http://www. elkerliek.nl/elkerliek.nl/specialismen/AKL/De%20kunst%20van%20het%20doseren.pdf.
  • 13
    • 84982299834 scopus 로고    scopus 로고
    • Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry
    • PMID: 27552578
    • Oh S, Goto S, Accetta G, Angchaisuksiri P, Camm AJ, Cools F, et al. Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry. Int J Cardiol. 2016; 223:543-7. doi: 10.1016/j.ijcard.2016.08.236 PMID: 27552578.
    • (2016) Int J Cardiol , vol.223 , pp. 543-547
    • Oh, S.1    Goto, S.2    Accetta, G.3    Angchaisuksiri, P.4    Camm, A.J.5    Cools, F.6
  • 14
    • 84904133274 scopus 로고    scopus 로고
    • Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: A meta-analysis and meta-regression
    • PMID: 25024644; PubMed Central PMCID: PMCPMC4094926
    • Mearns ES, White CM, Kohn CG, Hawthorne J, Song JS, Meng J, et al. Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J. 2014; 12:14. doi: 10.1186/1477-9560-12-14 PMID: 25024644; PubMed Central PMCID: PMCPMC4094926.
    • (2014) Thromb J , vol.12 , pp. 14
    • Mearns, E.S.1    White, C.M.2    Kohn, C.G.3    Hawthorne, J.4    Song, J.S.5    Meng, J.6
  • 15
    • 0029741822 scopus 로고    scopus 로고
    • An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation
    • PMID: 8678931
    • Hylek EM, Skates SJ, Sheehan MA, Singer DE. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med. 1996; 335(8):540-6. doi: 10.1056/NEJM199608223350802 PMID: 8678931.
    • (1996) N Engl J Med , vol.335 , Issue.8 , pp. 540-546
    • Hylek, E.M.1    Skates, S.J.2    Sheehan, M.A.3    Singer, D.E.4
  • 16
    • 80155179455 scopus 로고    scopus 로고
    • Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients
    • PMID: 21901239
    • Gallagher AM, Setakis E, Plumb JM, Clemens A, van Staa TP. Risks of stroke and mortality associated with suboptimal anticoagulation in atrial fibrillation patients. Thromb Haemost. 2011; 106(5):968-77. doi: 10.1160/TH11-05-0353 PMID: 21901239.
    • (2011) Thromb Haemost , vol.106 , Issue.5 , pp. 968-977
    • Gallagher, A.M.1    Setakis, E.2    Plumb, J.M.3    Clemens, A.4    Van Staa, T.P.5
  • 18
    • 84904958211 scopus 로고    scopus 로고
    • Initiation of warfarin in patients with atrial fibrillation: Early effects on ischaemic strokes
    • Epub 2013/12/20. PMID: 24353282
    • Azoulay L, Dell'Aniello S, Simon TA, Renoux C, Suissa S. Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes. Eur Heart J. 2014; 35(28):1881-7. Epub 2013/12/20. doi: 10.1093/eurheartj/eht499 PMID: 24353282.
    • (2014) Eur Heart J , vol.35 , Issue.28 , pp. 1881-1887
    • Azoulay, L.1    Dell'Aniello, S.2    Simon, T.A.3    Renoux, C.4    Suissa, S.5
  • 19
    • 0034565161 scopus 로고    scopus 로고
    • Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
    • PMID: 25092359
    • Middeldorp S, Prins MH, Hutten BA. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2014; 8:CD001367. doi: 10.1002/ 14651858.CD001367.pub3 PMID: 25092359.
    • (2014) Cochrane Database Syst Rev , vol.8 , pp. CD001367
    • Middeldorp, S.1    Prins, M.H.2    Hutten, B.A.3
  • 20
    • 84993986729 scopus 로고    scopus 로고
    • Using Data to Guide Anticoagulation in Patients With Atrial Fibrillation: Does the Analysis Fit the Question?
    • PMID: 27437881
    • Alexander JH, Thomas LE. Using Data to Guide Anticoagulation in Patients With Atrial Fibrillation: Does the Analysis Fit the Question? JAMA Cardiol. 2016; 1(2):121-2. doi: 10.1001/jamacardio.2016. 0198 PMID: 27437881.
    • (2016) JAMA Cardiol , vol.1 , Issue.2 , pp. 121-122
    • Alexander, J.H.1    Thomas, L.E.2
  • 21
    • 84907616635 scopus 로고    scopus 로고
    • SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation
    • Epub 2014/05/27. PMID: 24858062
    • Gallego P, Roldan V, Marin F, Galvez J, Valdes M, Vicente V, et al. SAMe-TT2R2 score, time in therapeutic range, and outcomes in anticoagulated patients with atrial fibrillation. Am J Med. 2014; 127 (11):1083-8. Epub 2014/05/27. doi: 10.1016/j.amjmed.2014.05.023 PMID: 24858062.
    • (2014) Am J Med , vol.127 , Issue.11 , pp. 1083-1088
    • Gallego, P.1    Roldan, V.2    Marin, F.3    Galvez, J.4    Valdes, M.5    Vicente, V.6
  • 22
    • 84901644405 scopus 로고    scopus 로고
    • Relationship of the SAMe-TT(2)R(2) score to poorquality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation
    • PMID: 24722973
    • Lip GY, Haguenoer K, Saint-Etienne C, Fauchier L. Relationship of the SAMe-TT(2)R(2) score to poorquality anticoagulation, stroke, clinically relevant bleeding, and mortality in patients with atrial fibrillation. Chest. 2014; 146(3):719-26. doi: 10.1378/chest.13-2976 PMID: 24722973.
    • (2014) Chest , vol.146 , Issue.3 , pp. 719-726
    • Lip, G.Y.1    Haguenoer, K.2    Saint-Etienne, C.3    Fauchier, L.4
  • 23
    • 84929233413 scopus 로고    scopus 로고
    • Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists
    • PMID: 25662984
    • Abumuaileq RR, Abu-Assi E, Raposeiras-Roubin S, Lopez-Lopez A, Redondo-Dieguez A, Alvarez-Iglesias D, et al. Evaluation of SAMe-TT2R2 risk score for predicting the quality of anticoagulation control in a real-world cohort of patients with non-valvular atrial fibrillation on vitamin-K antagonists. Europace. 2015; 17(5):711-7. doi: 10.1093/europace/euu353 PMID: 25662984.
    • (2015) Europace , vol.17 , Issue.5 , pp. 711-717
    • Abumuaileq, R.R.1    Abu-Assi, E.2    Raposeiras-Roubin, S.3    Lopez-Lopez, A.4    Redondo-Dieguez, A.5    Alvarez-Iglesias, D.6
  • 24
    • 84962090115 scopus 로고    scopus 로고
    • Use of the SAMe-TT2R2 score to predict good anticoagulation control with warfarin in chinese patients with atrial fibrillation: Relationship to ischemic stroke incidence
    • PMID: 27010633; PubMed Central PMCID: PMCPMC4807017
    • Chan PH, Hai JJ, Chan EW, Li WH, Tse HF, Wong IC, et al. Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence. PLoS One. 2016; 11(3):e0150674. doi: 10.1371/journal.pone.0150674 PMID: 27010633; PubMed Central PMCID: PMCPMC4807017.
    • (2016) PLoS One , vol.11 , Issue.3 , pp. e0150674
    • Chan, P.H.1    Hai, J.J.2    Chan, E.W.3    Li, W.H.4    Tse, H.F.5    Wong, I.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.